ARTICLE | Company News
Antitope, ChemomAb deal
August 5, 2013 7:00 AM UTC
The companies partnered to generate humanized mAbs devoid of T cell epitopes to treat inflammatory diseases using Antitope's Composite Human Antibody technology. Antitope said the deal combines its hu...